ZYNE: Nano-Cap Company That Is Focused On Treatments For Neuropsychiatric Disorders
February 20, 2023 at 10:00 AM EST
Given the progress of its clinical trials, and its latest quarterly financials, Zynerba appears to be an excellent buy-and-hold investment consideration.
